FUJIFILM Holdings (4901) AI Stock Analysis

• Market Cap: ¥4.17T
• Dividend Yield: 2.02%
• Average Volume (3M): 3.37M
• Price to Earnings (P/E): 15.4
• Beta (1Y): 0.96
• Revenue Growth: 5.39%
• EPS Growth: 12.69%
• Country: JP
• Employees: 72,254
• Sector: Industrials
• Sector Strength: 72
• Industry: Business Equipment & Supplies
• EPS (TTM): 55.16
• Shares Outstanding: 1,243,877,200
• 10 Day Avg. Volume: 3,791,640
• 30 Day Avg. Volume: 3,374,296
• PEG Ratio: 1.77
• Price to Book (P/B): 1.02
• Price to Sales (P/S): 1.07
• P/FCF Ratio: -45.86
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥4,020.75
• Price Target Upside: 15.51% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 72 Outperform
• Price Target: ¥3,734.00 ▲(7.27% Upside)

FUJIFILM Holdings maintains a solid financial position with strong revenue growth and profitability, though cash flow management presents challenges. The technical analysis indicates mixed signals, with the stock trading below key moving averages but not showing signs of being overbought. The valuation is reasonable, supported by a moderate P/E ratio and dividend yield.

Positive Factors

Revenue Growth

Consistent revenue growth indicates robust market demand and effective business strategies, supporting long-term financial stability.

Profitability

Sustained profitability margins reflect efficient operations and pricing power, contributing to durable competitive advantage.

Balance Sheet Strength

A strong balance sheet with low leverage enhances financial flexibility and resilience against economic fluctuations.

Negative Factors

Cash Flow Challenges

Negative free cash flow suggests potential liquidity issues, which could constrain investment and growth opportunities.

Debt Levels

Rising debt levels, although currently low, could impact future financial health if not managed carefully.

EBITDA Margin Decline

A decline in EBITDA margin may indicate rising costs or pricing pressures, affecting future profitability.

FUJIFILM Holdings Business Overview & Revenue Model

Company Description

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the three areas of prevention, diagnosis, and treatment. Its Materials segment offers inkjet digital presses and printing plates for printing industries, as well as industrial inkjet-related products and inkjet heads; storage media and archiving services to save and manage digital data volumes; and materials for industrials, including display and touch panel, semiconductor and image sensor, and functional film materials. The company's Business Innovation segment provides devices and services used in offices, including digital multifunction devices, printers, software, and cloud services; workflow solutions for printing companies and others in the graphical communications sector; and document services tailored to diverse business formats and roles, including system integration, business process outsourcing, and others. Its Imaging segment offers color films, instant cameras, developing and printing systems, color papers, and photo printing services; and TV and cinema lenses, surveillance cameras, industrial lenses for production line inspection, and projectors. FUJIFILM Holdings Corporation was incorporated in 1934 and is headquartered in Tokyo, Japan.

How the Company Makes Money

FUJIFILM generates revenue through multiple key streams, primarily by selling a wide range of products and services in its imaging and healthcare sectors. The imaging division includes the sale of digital cameras, photographic films, and printing solutions, which cater to both consumer and professional markets. In the healthcare sector, the company earns revenue from medical imaging systems and related services, including diagnostic equipment and IT solutions for healthcare facilities. Additionally, FUJIFILM has a strong presence in the pharmaceuticals market, focusing on biopharmaceutical production and development, which contributes significantly to its earnings. The company also pursues strategic partnerships and collaborations, particularly in the healthcare sector, which enhance its product offerings and expand its market reach, further bolstering its revenue generation capabilities.

FUJIFILM Holdings Financial Statement Overview

Summary

FUJIFILM Holdings shows strong revenue growth and solid profitability margins, with a robust balance sheet characterized by low leverage. However, cash flow challenges, particularly negative free cash flow due to high capital expenditures, indicate a need for strategic adjustments.

Income Statement

FUJIFILM Holdings has demonstrated strong revenue growth over the years, with a notable increase of approximately 8% from 2024 to 2025. The company maintains a healthy gross profit margin of around 40.7% in 2025, indicating efficient production and cost management. The net profit margin also shows robustness at 8.2%. Despite these strengths, there is room for improvement in EBIT and EBITDA margins, which stand at 10.3% and 16% respectively, suggesting potential areas for operational efficiency enhancements.

Balance Sheet

The balance sheet of FUJIFILM Holdings reflects a solid equity base, with a debt-to-equity ratio of 0.24, highlighting a conservative leverage approach. The equity ratio at 63.8% further underscores financial stability. With a return on equity of 7.8%, the company exhibits a moderate ability to generate profit from shareholders' investments. However, an increasing trend in total liabilities suggests that careful management is needed to maintain this stability.

Cash Flow

Cash flow analysis indicates a challenging environment, with negative free cash flow in recent years. Despite a strong operating cash flow to net income ratio of 1.64, signaling effective cash generation from operations, the free cash flow to net income ratio is negative, pointing to high capital expenditures that could restrain liquidity if not managed. The company needs to address these capital outflows to enhance free cash flow generation.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	3.25T	3.20T	2.96T	2.86T	2.53T	2.19T
Gross Profit	1.32T	1.30T	1.19T	1.14T	1.03T	869.69B
EBITDA	480.46B	512.91B	426.74B	415.29B	362.70B	288.90B
Net Income	270.75B	260.95B	243.51B	219.42B	211.18B	181.21B
Balance Sheet
Total Assets	5.53T	5.25T	4.78T	4.13T	3.96T	3.55T
Cash, Cash Equivalents and Short-Term Investments	160.88B	172.11B	179.72B	268.61B	486.33B	394.80B
Total Debt	922.82B	802.28B	607.63B	536.90B	588.82B	609.58B
Total Liabilities	2.04T	1.90T	1.61T	1.35T	1.43T	1.33T
Stockholders Equity	3.49T	3.35T	3.17T	2.76T	2.50T	2.20T
Cash Flow
Free Cash Flow	-103.93B	-74.63B	-56.77B	-113.02B	158.03B	295.25B
Operating Cash Flow	422.35B	428.16B	407.94B	210.45B	323.93B	420.86B
Investing Cash Flow	-535.75B	-541.95B	-527.42B	-323.23B	-153.54B	-279.38B
Financing Cash Flow	87.65B	108.88B	-462.00M	-123.69B	-105.18B	-163.09B

FUJIFILM Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3481.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4901, the sentiment is Positive. The current price of 3481 is above the 20-day moving average (MA) of 3321.30, above the 50-day MA of 3446.22, and above the 200-day MA of 3220.50, indicating a bullish trend. The MACD of -0.49 indicates Negative momentum. The RSI at 61.58 is Neutral, neither overbought nor oversold. The STOCH value of 89.08 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4901.

FUJIFILM Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8060	79 Outperform	¥765.29B	19.21	10.63%	2.01%	5.40%	23.70%
6448	76 Outperform	¥792.31B	14.39	7.77%	3.23%	4.30%	78.29%
7752	74 Outperform	¥787.89B	13.01	5.91%	2.81%	4.46%	70.22%
4901	72 Outperform	¥4.17T	15.43	7.92%	2.02%	5.39%	12.69%
7984	72 Outperform	¥426.25B	19.22	8.83%	2.22%	6.29%	8.74%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
4902	55 Neutral	¥353.20B	-25.48	-12.69%	0.69%	-11.22%	-731.07%

FUJIFILM Holdings Corporate Events

FUJIFILM Reports Record Q1 Earnings Amid Challenges

In a recent earnings call, FUJIFILM Holdings Corp reported a strong performance with record highs in revenue and operating income for Q1. The company highlighted growth in its Bio CDMO and imaging segments, despite facing challenges from foreign exchange losses and tariffs. The overall sentiment was positive, with an upward revision of the full-year forecast and continuous dividend growth.